These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening pregnant women for HIV antibody: cost-benefit analysis. Houshyar A AIDS Public Policy J; 1991; 6(2):98-103. PubMed ID: 11652064 [No Abstract] [Full Text] [Related]
3. Cost-effectiveness analysis of the intensified campaign against smallpox in India. Ramaiah TJ NIHAE Bull; 1976; 9(3):205-19. PubMed ID: 829271 [No Abstract] [Full Text] [Related]
4. The cost of contraceptive supplies. Saunders RS Finance Dev; 1976; 13(4):43-4. PubMed ID: 12261068 [No Abstract] [Full Text] [Related]
5. Micro/macro cost-benefit analyses prove new data system's value to hospital, community. Kim SH; Schmitz HH Hosp Financ Manage; 1975 Oct; 29(10):48-53. PubMed ID: 10308686 [No Abstract] [Full Text] [Related]
6. Justifying alcohol treatment on the basis of cost savings. The "offset" literature. Luckey JW Alcohol Health Res World; 1987; 12(1):8-15. PubMed ID: 10312354 [No Abstract] [Full Text] [Related]
7. Cost considerations for long-term mechanical circulatory support. Oz MC; Grewal R; Gelijn A ASAIO J; 1997; 43(4):268-70. PubMed ID: 9242938 [No Abstract] [Full Text] [Related]
9. Data gathering systems in evaluation and research. Rosenberg G J Natl Assoc Priv Psychiatr Hosp; 1976; 8(3):31-4. PubMed ID: 829258 [No Abstract] [Full Text] [Related]
10. [Evaluation of medical practices]. Battista RN Union Med Can; 1980 Oct; 109(10):1462-7. PubMed ID: 6781111 [No Abstract] [Full Text] [Related]
11. Data unto the day patient. Bates T; Hamm J Health Serv J; 1989 Mar; 99(5140):266. PubMed ID: 10318198 [No Abstract] [Full Text] [Related]
12. Measuring managed care: does it really save money? Grimaldi PL Healthc Financ Manage; 1988 Apr; 42(4):25-8, 30, 32. PubMed ID: 10312426 [TBL] [Abstract][Full Text] [Related]
13. [Clinical decision analysis. Contribution of information from diagnostic tests to the decision-making process. I--Statistical and economic interpretation of information from non-invasive tests]. Coelho G; Gonçalves FR; Cerqueira-Gomes M Rev Port Cardiol; 1990 Jun; 9(6):531-5. PubMed ID: 2123393 [No Abstract] [Full Text] [Related]
14. Cost-benefit issues in U.S. national health legislation: the case of the End-Stage Renal Disease Program. Kutner NG Soc Probl; 1982 Oct; 30(1):51-64. PubMed ID: 11653717 [No Abstract] [Full Text] [Related]
15. The importance of subjective values to medical technology assessment and health policy. Diamond GA J Invasive Cardiol; 1993; 5(1):17-22. PubMed ID: 10148297 [No Abstract] [Full Text] [Related]
16. The role of new laboratory tests in clinical decision-making. Beck JR Clin Lab Med; 1982 Dec; 2(4):751-77. PubMed ID: 6819109 [No Abstract] [Full Text] [Related]
17. Measurement and expression of treatment effects in caries clinical trials. Horowitz HS J Dent Res; 1984 May; 63 Spec No():709-14. PubMed ID: 6427311 [No Abstract] [Full Text] [Related]
18. The baby myth. Begley S; Brant M; Springen K; Rogers A Newsweek; 1995 Sep; 126(10):38-47. PubMed ID: 11653218 [No Abstract] [Full Text] [Related]
19. Motives for joining professional associations: a test of Oldon's exchange theory. Yeager SJ J Health Hum Resour Adm; 1983; 5(3):334-50. PubMed ID: 10309957 [No Abstract] [Full Text] [Related]